Metraipolis › archive › dc_0da5b4804cbd
Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program — Europe PMC PMID:25905001
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/25905001
- DOI
- 10.1186/2045-3329-4-17
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T12:27:00.643Z
- SHA-256 of the archived text
d6e4df405722d28f7f327cb9ada3f0ee891cec3d1b97ea0470266895f90ec03e- Stable URL of this page
https://metraipolis.com/documento/dc_0da5b4804cbd
How to cite
Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program — Europe PMC PMID:25905001 — Europe PMC (en), https://europepmc.org/article/MED/25905001 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0da5b4804cbd (Metraipolis archive dc_0da5b4804cbd, sha256 d6e4df405722d28f7f327cb9ada3f0ee891cec3d1b97ea0470266895f90ec03e)
BibTeX
@misc{dc0da5b4804cbd,
title = {Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program — Europe PMC PMID:25905001},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/25905001},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0da5b4804cbd; sha256 d6e4df405722d28f7f327cb9ada3f0ee891cec3d1b97ea0470266895f90ec03e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/25905001. Agents can read the archived copy with the MCP tool read_document.